Chemours Co (CC) Receives Consensus Rating of “Hold” from Analysts

Share on StockTwits

Shares of Chemours Co (NYSE:CC) have received a consensus recommendation of “Hold” from the thirteen research firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating on the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $59.22.

A number of analysts have issued reports on the stock. Citigroup cut their price target on shares of Chemours from $69.00 to $64.00 and set a “buy” rating on the stock in a research note on Wednesday, July 11th. ValuEngine lowered shares of Chemours from a “sell” rating to a “strong sell” rating in a research note on Thursday, August 2nd. Barclays reiterated a “buy” rating and set a $62.00 price target on shares of Chemours in a research note on Tuesday, August 7th. BMO Capital Markets cut their price target on shares of Chemours from $70.00 to $68.00 and set an “outperform” rating on the stock in a research note on Monday, August 6th. Finally, SunTrust Banks assumed coverage on shares of Chemours in a research note on Tuesday, July 31st. They set a “hold” rating and a $51.00 price target on the stock.

NYSE CC traded up $0.35 during trading hours on Monday, reaching $44.00. The company had a trading volume of 1,393,032 shares, compared to its average volume of 1,229,792. Chemours has a 1-year low of $42.00 and a 1-year high of $58.08. The company has a debt-to-equity ratio of 3.86, a current ratio of 2.09 and a quick ratio of 1.47. The stock has a market capitalization of $7.72 billion, a P/E ratio of 11.52, a PEG ratio of 0.48 and a beta of 2.73.

Chemours (NYSE:CC) last posted its earnings results on Thursday, August 2nd. The specialty chemicals company reported $1.71 EPS for the quarter, beating the Zacks’ consensus estimate of $1.53 by $0.18. The company had revenue of $1.82 billion for the quarter, compared to analysts’ expectations of $1.82 billion. Chemours had a net margin of 15.11% and a return on equity of 107.22%. Chemours’s revenue for the quarter was up 14.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.87 earnings per share. analysts anticipate that Chemours will post 5.81 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 14th. Investors of record on Friday, August 17th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.27%. This is a positive change from Chemours’s previous quarterly dividend of $0.17. The ex-dividend date is Thursday, August 16th. Chemours’s dividend payout ratio is presently 26.18%.

Hedge funds have recently added to or reduced their stakes in the stock. WINTON GROUP Ltd increased its stake in Chemours by 40.9% in the second quarter. WINTON GROUP Ltd now owns 115,354 shares of the specialty chemicals company’s stock valued at $5,117,000 after purchasing an additional 33,510 shares during the last quarter. Andra AP fonden increased its stake in Chemours by 3.4% in the second quarter. Andra AP fonden now owns 113,000 shares of the specialty chemicals company’s stock valued at $5,013,000 after purchasing an additional 3,700 shares during the last quarter. Tiedemann Advisors LLC purchased a new position in Chemours in the second quarter valued at approximately $351,000. Cozad Asset Management Inc. purchased a new position in Chemours in the second quarter valued at approximately $276,000. Finally, Worldquant Millennium Quantitative Strategies LLC purchased a new position in Chemours in the second quarter valued at approximately $488,000. Hedge funds and other institutional investors own 76.73% of the company’s stock.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging.

See Also: Penny Stocks, What You Need To Know

Analyst Recommendations for Chemours (NYSE:CC)

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply